Choi Jay Chol, Jang Min Uk, Kang Kyusik, Park Jong-Moo, Ko Youngchai, Lee Soo-Joo, Cha Jae-Kwan, Kim Dae-Hyun, Park Sang Soon, Park Tai Hwan, Lee Kyung Bok, Lee Jun, Kim Joon-Tae, Cho Ki-Hyun, Yu Kyung-Ho, Oh Mi-Sun, Lee Byung-Chul, Cho Yong-Jin, Kim Dong-Eog, Lee Ji Sung, Lee Juneyoung, Gorelick Philip B, Bae Hee-Joon
J Am Heart Assoc. 2015 Jan 27;4(1):e001306. doi: 10.1161/JAHA.114.000596.
One third of patients presenting with initially mild strokes have unfavorable outcomes, and the efficacy of intravenous thrombolysis (IVT) in this population has not been proven. This study aimed to evaluate the comparative effectiveness of standard care with IVT versus without IVT in mild stroke patients.
Using a multicenter stroke registry database, we identified patients with acute ischemic stroke who presented within 4.5 hours of symptom onset and had initial National Institutes of Health Stroke Scale scores ≤5. Multivariable logistic analysis and propensity score matching were used to adjust for baseline imbalances between the patients who did and did not receive IVT. Adjusted odds ratios and 95% CIs of IVT were estimated for 3-month modified Rankin Scale scores of 0 to 1 and symptomatic. Of 13 117 patients with stroke who were hospitalized between April 2008 and May 2012, 1386 met the eligibility criteria, and 194 (14.0%) were treated with IVT. For a modified Rankin Scale of 0 to 1 at 3 months, the adjusted odds ratios were 1.96 (95% CI, 1.28 to 3.00; P=0.002) by multivariable logistic analysis and 1.68 (1.10 to 2.56; P=0.02) by propensity score matching analysis, respectively. There was a statistically nonsignificant excess of symptomatic hemorrhagic transformation (odds ratios=3.76 [0.95 to 16.42; P=0.06] and 4.81 [0.84 to 49.34; P=0.09]), respectively.
In this observational registry-based study, standard care with IVT is more effective than not receiving IVT in mildischemic stroke patients, and there is a statistically nonsignificant risk of symptomatic hemorrhagic transformation.
最初表现为轻度卒中的患者中有三分之一预后不佳,而静脉溶栓(IVT)在这一人群中的疗效尚未得到证实。本研究旨在评估轻度卒中患者接受IVT标准治疗与未接受IVT标准治疗的相对有效性。
利用多中心卒中登记数据库,我们识别出症状发作4.5小时内就诊且初始美国国立卫生研究院卒中量表评分≤5分的急性缺血性卒中患者。采用多变量逻辑分析和倾向评分匹配来调整接受和未接受IVT患者之间的基线不平衡。估计IVT的调整比值比和95%置信区间用于3个月改良Rankin量表评分为0至1分且有症状的情况。在2008年4月至2012年5月期间住院的13117例卒中患者中,1386例符合纳入标准,194例(14.0%)接受了IVT治疗。对于3个月时改良Rankin量表评分为0至1分,多变量逻辑分析的调整比值比为1.96(95%置信区间,1.28至3.00;P = 0.002),倾向评分匹配分析的调整比值比为1.68(1.10至2.56;P = 0.02)。症状性出血转化分别有统计学上无显著意义的增加(比值比分别为3.76 [0.95至16.42;P = 0.06]和4.81 [0.84至49.34;P = 0.09])。
在这项基于观察性登记的研究中,对于轻度缺血性卒中患者,接受IVT标准治疗比未接受IVT更有效,且症状性出血转化风险在统计学上无显著意义。